Medicine

Integrating liver endpoints in clinical trials of cardiovascular as well as renal disease

.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view asks for addition of clients along with MASLD as well as dimension of liver results in cardio-- renal-- metabolic tests, when records suggest mechanistically possible benefits as well as scientific safety and security-- and also summarizes factors to consider for trial layout as well as regulative commendation.